“The [issuer] downgrade reflects significantly negative operating results and thin coverage while a lower rating is precluded by SAMC’s relatively stable and ample unrestricted reserves, which cover its outstanding debt by 1.7x,” said S&P analyst Cynthia Keller.
The outlook is negative, reflecting S&P Global Ratings’ expectation SAMC’s financial turnaround efforts remain challenging and its margins may not improve sufficiently during the two-year outlook period.
More articles on healthcare finance:
Moody’s revises Integris Health’s outlook to negative
Kindred Healthcare records $15.4M net loss in Q4
Moody’s affirms ‘A1’ rating on Hawaii Pacific Health’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
